Lierre Grimpant Eg Labo Conseil Sans Sucre

Ivy leaf dry extract, the active ingredient in Lierre Grimpant Eg Labo Conseil Sans Sucre, is a herbal extract presented as a dry oral preparation for oral use. It has been traditionally employed to support respiratory health in adults, particularly in cases of cough and mucus congestion.

GNH USA supplies Lierre Grimpant Eg Labo Conseil Sans Sucre as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution.

Ivy leaf dry extract is traditionally used to address symptoms within the respiratory tract and related mucosal irritation.

- Cough: may reduce the frequency and intensity of productive coughs, supporting clearer breathing. - Bronchial congestion: can assist in loosening mucus, facilitating expectoration and improving airway patency. - Upper respiratory irritation: may soothe throat irritation and reduce discomfort associated with minor colds. - Post‑viral recovery: may aid in restoring normal respiratory function after viral upper‑respiratory infections.

Ivy leaf dry extract may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Taste disturbance: bitter or unusual aftertaste. - Dizziness: transient light‑headedness. - Skin irritation: mild rash or itching at the site of contact.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis with swelling, difficulty breathing. - Bronchospasm: paradoxical tightening of airways. - Hepatic dysfunction: elevated liver enzymes. - Significant gastrointestinal bleeding: rare but serious.

When considering Ivy leaf dry extract, several precautionary measures should be observed to ensure safe use. - Pregnancy: safety not established; avoid unless benefits outweigh potential risks. - Breastfeeding: unknown safety profile; consider discontinuation if infant shows adverse effects. - Children: not recommended for use in children under 12 years of age. - Drug interactions: avoid concurrent use with potent cough suppressants without medical guidance. - Allergy: discontinue immediately if signs of hypersensitivity such as rash or swelling occur. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ivy leaf dry extract can interact with other medicines; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Concurrent use with strong cough suppressants (e.g., codeine) may diminish the expectorant effect. - Combination with known allergens may heighten risk of severe hypersensitivity reactions.

Moderate Interactions (Monitor Closely): - Use with anticoagulant therapy may increase risk of gastrointestinal bleeding; monitor coagulation parameters. - Co‑administration with other herbal expectorants may potentiate mucus‑clearing effects, possibly causing excess sputum. - Concomitant use with monoamine oxidase inhibitors may theoretically raise blood pressure; observe for hypertensive signs.